Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Still no exodus of British hedge fund managers in sight

Tuesday, January 12, 2010

From the Opalesque team:

Still no exodus of British hedge fund managers in sight, claimed Swiss daily paper Le Temps yesterday.

Only a handful so far have made a move, among them, Bluegold, CQS Asset Management, Tiresias Capital in collaboration with Omni Partners, and the American fund firm Arrowhawk Capital Partners. According the Swiss Funds Association, between 10 and 20 hedge funds from various origins have come to settle in the last 24 months.

Most have opened a satellite office with 2 or 3 people – sometimes a few more – usually including a marketer who is in charge of relations with investors, a lot of them being based in Switzerland.

However, neither of the large fund houses BlueCrest Capital Management or Brevan Howard has yet opened the Swiss office they said they would open. Both said they planned to move around 20% of their staff to Geneva.

Others, such as Emergent Asset Management and Odey Asset Management, have looked into moving but have not reached a decision, apparently. They are two of many to do this. Palladio Alternative Research in Geneva confirmed that the biggest hedge fund houses are indeed the ones who make enquiries. A company in Lausanne, which has received 30 enquiries, said there is also marked interest from smaller independent funds.

April will determine whether the tax increase will spur hedge funds to move out of the UK, the paper concludes.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner